PSA financial statements and SEC filings
PSA annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $4.82B | – | $1.59B | 10-K |
| 2024-12-31 | $4.70B | – | $1.87B | 10-K |
| 2023-12-31 | $4.52B | – | $1.95B | 10-K |
| 2022-12-31 | $4.18B | – | $4.14B | 10-K |
| 2021-12-31 | $3.42B | – | $1.73B | 10-K |
| 2020-12-31 | $2.92B | – | $1.10B | 10-K |
PSA annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $20.21B | $10.87B | $9.34B | 10-Q |
| 2024-12-31 | $19.75B | $9.94B | $9.81B | 10-K |
| 2023-12-31 | $19.81B | $9.70B | $10.11B | 10-K |
| 2022-12-31 | $17.55B | $7.39B | $10.17B | 10-K |
| 2021-12-31 | $17.38B | $7.96B | $9.36B | 10-K |
| 2020-12-31 | $11.82B | $3.24B | $8.58B | 10-K |
PSA annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $3.19B | -$310.74M | -$1.63B | 10-K |
| 2024-12-31 | $3.13B | -$326.85M | -$2.08B | 10-K |
| 2023-12-31 | $3.25B | -$364.44M | -$112.93M | 10-K |
| 2022-12-31 | $3.12B | -$313.51M | -$4.19B | 10-K |
| 2021-12-31 | $2.54B | -$281.98M | $3.50B | 10-K |
| 2020-12-31 | $2.04B | – | -$1.08B | 10-K |